E-cigarette companies in the US will now have until September 9 to submit their vaping product applications, reported Medical Xpress.

The Food and Drug Administration (FDA) announced April 23 that a federal court accepted its request to push the original deadline date, May 12, back to September 9, due to delays tied to the coronavirus outbreak. The FDA said the pandemic had caused delays both for its own staff and for the companies submitting applications.
The review is part of the FDA’s overall effort to regulate the vaping industry in the US, including thousands of e-cigarettes and flavoured solutions. Despite appearing on the market on the US more than a decade ago, e-cigarettes have been under relatively little federal regulation. Health advocacy groups successfully sued the FDA last year, after a surge in underage vaping, and the court ordered the FDA to set the May 12 application deadline as a response.
According to the report, FDA Commissioner, Dr Stephen Hahn, said in a statement that e-cigarette companies have faced problems completing their research due to travel restrictions and limited laboratory access. Hahn also stated that many FDA staff who would have reviewed the applications are now assisting with the pandemic response.